-
EASE OF USE OF TIRZEPATIDE: RESULTS FROM A US SURVEY OF INDIVIDUALS WITH OBESITY OR OVERWEIGHT
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE USE OF DIGITAL HEALTH TECHNOLOGY-DERIVED ENDPOINTS TO CAPTURE PATIENT EXPERIENCE DATA IN CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
HEALTHCARE COSTS AND CLINICAL OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MASH OR SUSPECTED MASH WITH HIGH FIB-4 SCORE IN U.S. ADULTS
Mar 18, 2026, 21:38 PM -
BREAK EVEN ANALYSIS FOR CONTRACEPTION PRESCRIBING SERVICES IN COMMUNITY PHARMACIES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF TRIFLURIDINE/TIPIRACIL PLUS BEVACIZUMAB VERSUS REGORAFENIB IN REFRACTORY METASTATIC COLORECTAL CANCER IN KAZAKHSTAN
Mar 18, 2026, 21:38 PM -
SHOULD PHASE 2 STUDIES BE ROUTINELY EXCLUDED IN COMPARATIVE EFFECTIVENESS ITCS?
Mar 18, 2026, 21:38 PM -
IMPACT OF THE COVID-19 PANDEMIC ON HEALTHCARE EXPENDITURE AND RESOURCE USE IN PEOPLE LIVING WITH HIV IN THE UNITED STATES: A DIFFERENCE-IN-DIFFERENCE ANALYSIS
Mar 18, 2026, 21:38 PM -
WHAT MATTERS MOST TO PATIENTS IN WARFARIN MODELS OF CARE: A QUALITATIVE STUDY
Mar 18, 2026, 21:38 PM -
A NOVEL APPROACH FOR GENERATING ROBUST POPULATION ESTIMATES FOR USE IN HTA AND REGULATORY SUBMISSIONS: DEMONSTRATION IN CLL IN GERMANY
Mar 18, 2026, 21:38 PM -
EVALUATING THE IMPACT OF MONETARY INCENTIVES ON HEALTH EQUITY : A DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS OF COVID-19 VACCINATION STRATEGIES
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION, EXPENDITURES, AND HEALTH-RELATED QUALITY OF LIFE AMONG U.S. ADULTS WITH RHEUMATOID ARTHRITIS AND COMORBID HYPERTENSION: MEDICAL EXPENDITURE PANEL SURVEY, 2020-2023
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE (RWE) ON BRUTON TYROSINE KINASE INHIBITORS (BTKIS) IN TREATMENT-NAIVE (TN) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL): AN ARTIFICIAL INTELLIGENCE (AI)-ASSISTED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
EXTENSION OF AGENT BASED MODELING IN CHINA’S NATIONAL VOLUME BASED DRUG PROCUREMENT: BIDDING SIMULATION AND POLICY IMPLICATIONS
Mar 18, 2026, 21:38 PM -
QUANTIFYING THE ECONOMIC BURDEN OF NEONATAL-ONSET ORNITHINETRANSCARBAMYLASEDEFICIENCY IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF THE ETONOGESTREL SUBDERMAL CONTRACEPTIVE IMPLANT (ESI) IN BRAZIL
Mar 18, 2026, 21:38 PM -
INVESTIGATING THE CHARACTERISTICS ASSOCIATED WITH PRESCRIBED OPIOID USE IN U.S. ADULTS WITH LONG COVID
Mar 18, 2026, 21:38 PM -
DEVELOPING A PATIENT-REPORTED OUTCOME (PRO) MEASURE FOR JAPANESE PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC)
Mar 18, 2026, 21:38 PM -
DIRECT MEDICAL COSTS IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): A REAL-WORLD EVIDENCE FROM FOUR CENTERS IN COLOMBIA
Mar 18, 2026, 21:38 PM -
CHARACTERISTICS, TREATMENT PATTERNS, AND OUTCOMES OF PATIENTS WITH NON-SMALL CELL LUNG CANCER ACROSS CLINICO-GENOMIC DATABASE AND ELECTRONIC MEDICAL RECORDS
Mar 18, 2026, 21:38 PM -
ENHANCING REAL-WORLD DATA (RWD) QUALITY: IMPLEMENTATION OF REGULATORY DATA QUALITY FRAMEWORK WITHIN A LARGE US ONCOLOGY ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATABASE
Mar 18, 2026, 21:38 PM
